As the here identified candidates VTRNA1-1, RNY1, and RNY4 have been suggested to distinguish cancer from normal counterparts24,27,28,42, and VTRNA1-1 also to inhibit apoptosis and affect chemoresistance62,63,65, they could have roles in the mechanisms that are involved also in the aggressiveness of TNBC. The gene discussed is RNY1; the disease is cancer.